Skip to content

INTERLEUKIN GENETICS INC: 10-Q filed 2016-08-15

What INTERLEUKIN GENETICS INC reported in its quarterly report filed 2016-08-15 (fiscal Q2 2016): 32 published measures, 92 facts as tagged in accession 0001144204-16-119521.

This filing

Form
10-Q (quarterly report)
Filed
2016-08-15
Fiscal period
fiscal Q2 2016
Accession
0001144204-16-119521 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All INTERLEUKIN GENETICS INC filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2016-06-302,651,681USD
At 2015-12-316,491,520USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2016-06-308,275,434USD
At 2015-12-318,952,920USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2016-06-30-5,623,753USD
At 2015-12-31-2,461,400USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2016-06-301,274,366USD
At 2015-12-314,706,018USD
At 2015-06-307,691,919USD
At 2014-12-3111,466,807USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-2,087,201USD91
2016-01-01 to 2016-06-30-3,604,936USD182
2015-01-01 to 2015-12-317,900,000USD365
2015-04-01 to 2015-06-30-2,166,786USD91
2015-01-01 to 2015-06-30-4,009,981USD181
2014-01-01 to 2014-12-316,300,000USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2016-01-01 to 2016-06-308,963USD182
2015-01-01 to 2015-06-3021,518USD181

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2016-04-01 to 2016-06-30590,209USD91
2016-01-01 to 2016-06-301,551,127USD182
2015-04-01 to 2015-06-30376,051USD91
2015-01-01 to 2015-06-30779,263USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2016-06-30-132,593,261USD
At 2015-12-31-128,988,325USD

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2016-04-01 to 2016-06-300USD91
2016-01-01 to 2016-06-300USD182
2015-04-01 to 2015-06-300USD91
2015-01-01 to 2015-06-300USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2016-06-30544,920USD
At 2015-12-31643,900USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2016-01-01 to 2016-06-30429,528USD182
2015-01-01 to 2015-06-30399,235USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-1,938,889USD91
2016-01-01 to 2016-06-30-3,304,521USD182
2015-04-01 to 2015-06-30-2,014,682USD91
2015-01-01 to 2015-06-30-3,707,246USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2016-06-302,036,606USD
At 2015-12-315,695,533USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2016-04-01 to 2016-06-30109,958USD91
2016-01-01 to 2016-06-30223,708USD182
2015-04-01 to 2015-06-30113,750USD91
2015-01-01 to 2015-06-30226,250USD181

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2016-06-305,985,616USD
At 2015-12-315,477,936USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2016-06-30769,992USD
At 2015-12-31408,374USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2016-06-303,755USD
At 2015-12-3145,973USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2016-04-01 to 2016-06-302,173,921USD91
2016-01-01 to 2016-06-303,973,525USD182
2015-04-01 to 2015-06-302,059,178USD91
2015-01-01 to 2015-06-303,823,913USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2016-06-3087,779USD
At 2015-12-31124,583USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2016-04-01 to 2016-06-30235,032USD91
2016-01-01 to 2016-06-30669,004USD182
2015-04-01 to 2015-06-3044,496USD91
2015-01-01 to 2015-06-30116,667USD181

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2016-04-01 to 2016-06-30355,177USD91
2016-01-01 to 2016-06-30882,123USD182
2015-04-01 to 2015-06-30331,555USD91
2015-01-01 to 2015-06-30662,596USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2016-04-01 to 2016-06-301,713,076USD91
2016-01-01 to 2016-06-303,024,261USD182
2015-04-01 to 2015-06-301,655,226USD91
2015-01-01 to 2015-06-303,218,017USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2016-04-01 to 2016-06-30452,483USD91
2016-01-01 to 2016-06-30932,539USD182
2015-04-01 to 2015-06-30384,538USD91
2015-01-01 to 2015-06-30567,068USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2016-06-30173,029,840shares
At 2015-12-31172,887,221shares

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2016-06-3042,154USD
At 2015-12-3158,879USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2016-06-3028,001USD
At 2015-12-3193,208USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2016-06-30529,636USD
At 2015-12-31497,688USD

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2016-04-01 to 2016-06-308,362USD91
2016-01-01 to 2016-06-3016,725USD182
2015-04-01 to 2015-06-3019,414USD91
2015-01-01 to 2015-06-3038,828USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2016-04-01 to 2016-06-30-148,312USD91
2016-01-01 to 2016-06-30-300,415USD182
2015-04-01 to 2015-06-30-152,104USD91
2015-01-01 to 2015-06-30-302,735USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-06-30-42,218USD182
2015-01-01 to 2015-06-30-6,390USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-06-30-36,804USD182
2015-01-01 to 2015-06-30-12,527USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2016-01-01 to 2016-06-30361,618USD182
2015-01-01 to 2015-06-30-153,689USD181

Inspect the source

Entity
INTERLEUKIN GENETICS INC / CIK 0001037649
Captured
SEC response SHA-256
a1dec64965ae0507fde1f8bdab94feeb924a2817b4582e8fe10de362809c5bbd

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001037649.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))